Zinc trial aims to boost immunity in HIV patients not helped by standard drugs
NCT ID NCT06612554
First seen Apr 21, 2026 · Last updated Apr 26, 2026 · Updated 1 time
Summary
This study tests whether taking 75 mg of zinc daily can improve immune function in people with HIV whose CD4 counts remain low despite antiretroviral therapy. About 120 participants will be randomly assigned to receive zinc or continue their usual care. The goal is to see if zinc increases CD4 cells, reduces inflammation, and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital del Mar
RECRUITINGBarcelona, 08003, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.